Page-2 of Drug Controller General of India

Indigenously Developed ‘COVAXIN’ gets DCGI approval for Human Clinical Trials

The Drug Controller General of India (DCGI) has given approval for Phase I and Phase II human clinical trials for COVID-19 vaccine ‘COVAXIN’. In association with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV), ..

Month: 

Cipla’s ‘Cipremi’ gets approval for Treatment of COVID-19 Patients in India

In its June 13th, 2020 guidelines for Clinical Management Protocol for COVID-19, the Union Health Ministry as a part of investigational therapy added ‘Remdesivir’ only for restricted emergency use. A week after, on 21st June 2020, Hetero and Cipla Pharmaceuticals ..

Month: 

Hetero’s injectable ‘Covifor’ gets DCGI approval for COVID-19 Treatment

For the treatment of COVID-19 positive cases, on 21st June 2020, Hyderabad based pharmaceutical company -Hetero Drugs has received approval from the Drug Controller General of India (a department under- CDSCO: Central Drugs Standard Control Organization) for manufacturing and marketing ..

Month: 

ICMR recommends hydroxy-chloroquine for high-risk coronavirus cases

The national task force for COVID-19 constituted by Indian Council for Medical Research (ICMR) has recommended hydroxy-chloroquine as a preventive drug for high-risk cases, who are infected by coronavirus. The medication should be given to the asymptomatic healthcare workers, who ..

Drugs and Clinical Trials Rules, 2019

The Union Ministry for Health and Family Welfare has notified the Drugs and Clinical Trials Rules, 2019 with an aim to promote clinical research in the country. Features of the New Rules The new rules reduce the time for approving ..

Month: 

Delhi high court bans online sale of medicines across India

In a landmark ruling, the Delhi High Court has ordered a ban on the sale of medicines online by e-pharmacists across India and has directed the Delhi government and the Centre to put the order into effect immediately. The order ..